Sales & Marketing Bluesky offers an opportunity pharma should not ignore As X becomes a battleground for increasingly polarised debate, its lesser-known (but strikingly similar) cousin Bluesky is rapidly gaining traction.
Oncology Inside ESMO 2024: Treatments, trials, and top HCPs on social... Discover the latest treatments, clinical trials, and top healthcare professionals sharing insights on social media from the ESMO 2024 conference.
Oncology On nuclear medicine and oncology, SHINE technologies Greg Piefer, founder and CEO of SHINE Technologies, discusses nuclear medicine and the role of radiopharmaceuticals in oncology.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face